Sep 20, 2023 / 07:40PM GMT
Joseph John-Charles Thome - TD Cowen, Research Division - MD & Senior Research Analyst
Hi, everyone. Thank you for joining us at our Third Annual Neuropsychiatry Summit. I'm Joe Thome, one of the senior biotech analysts here on the team at TD Cowen, and it is my pleasure to have with me today the team from Jazz Pharmaceuticals. We have: President and COO, Dan Swisher; the Executive Vice President and Global Head of Research and Development, Dr. Rob Iannone; the Head of Neuroscience and Clinical Development, Phil Jochelson. Thank you all very much for joining us today, and congrats on the progress.
Over the past year, we have a few exciting catalysts that we're going to get into throughout the discussion, but maybe I'll throw it over to the team, if you want to outline maybe some of the top recent progress, maybe on the neuroscience business, but overall as well, and kind of your outline goals for the next 12-months.
Daniel N. Swisher - Jazz Pharmaceuticals plc - Non-Executive Employee
Yes. Thanks a lot, Joe. It's great to be here.
Jazz Pharmaceuticals PLC at TD Cowen Novel Mechanisms in Neuropsychiatry Summit Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers